Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Theseus Pharmaceuticals
210 Broadway St
Cambridge, MA 02139
https://theseusrx.com/

Theseus Pharmaceuticals is passionately committed to outsmarting cancer resistance. The Company is developing best-in-class, pan-variant kinase inhibitors, to shape the future of targeted oncology. Theseus believes truly transformative, targeted oncology therapeutics must inhibit all clinically relevant variants. Led by a team of pioneers in the discovery and development of tyrosine kinase inhibitors (TKIs), the Company's technology can predict how a cancer will mutate, enabling Theseus to target known mutations, stay ahead of future variants, and overcome the demonstrated burden of treatment resistance. For more information, visit www.theseusrx.com.

Key Contact
Name
William C. Shakespeare, Ph.D
Title
Co-Founder
E-Mail
Funding Events

Date
Amount
Type
Investors
04/13/21 $100,000,000 Series B Adage Capital Management
Boxer Capital
Farallon Capital Management
Foresite Capital
Longitude Capital
Nextech Ventures
Omega Funds
OrbiMed Advisors
Pontifax
Rock Springs Capital
T. Rowe Price Associates


Featured Reading